Quest Diagnostics Incorporated · NYSE:DGX

T. Rowe Price Associates Inc reported a 5.40% stake in Quest Diagnostics Incorporated (Schedule 13G)

Event Mar 31, 2025 · Filed May 14, 2025

T. Rowe Price Associates Inc reported a 5.40% stake in Quest Diagnostics Incorporated, 5,995,335 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G).

Stake
5.40%
Shares
5,995,335
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.5.40%5,995,335

Source

View original at SEC

Related